Machine Learning-Based Classification of Antimicrobial Resistance in E. coli Genomes from Clinical Isolates

Research Summary:
Antimicrobial resistance (AMR) is a growing global health threat, making it harder to treat common infections. This research focuses on understanding resistance in Escherichia coli (E. coli), a bacteria that often causes infections in hospitals and the community.

By analyzing the genetic information of E. coli from clinical samples, we aim to identify patterns linked to resistance to antibiotics. The goal is to better understand how resistance develops and spreads, and how it can be detected early using genome data.

Why This Research Matters:
Improving Patient Outcomes: Faster detection of resistant bacteria can help doctors choose the right treatments, leading to quicker recovery and fewer complications.

Supporting Stewardship: Understanding resistance helps reduce unnecessary antibiotic use and protects the effectiveness of existing drugs.

Informing Public Health: The findings can guide surveillance and response to outbreaks of resistant infections.

Strengthening Health Systems: This research provides tools and knowledge that can improve diagnostics and infection control in hospitals and clinics.